Solving cancer resistance.
resistanceBio has raised $12.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2024.
resistanceBio's investors include Y Combinator, Alumni Ventures, Pioneer Fund, Fifty Years, Liquid 2 Ventures.
resistanceBio is headquartered in Menlo Park, United States.
Solving cancer resistance.
resistanceBio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"resistanceBio — Funding & Investors." VCBacked, January 31, 2024, https://www.vcbacked.co/company/resistancebio. Accessed July 19, 2026.
VCBacked. (2024). resistanceBio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/resistancebio
{{cite web |title=resistanceBio — Funding & Investors |url=https://www.vcbacked.co/company/resistancebio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated